))
Parents on a Mission
Manage episode 312495042 series 3236617
Content provided by David Cunnington and SCN2A Australia. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by David Cunnington and SCN2A Australia or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Having a child with SCN2A or other genetic epilepsy is challenging and the future is uncertain. When Alex Nemiroff’s son Roger was born, he was determined to work towards finding treatments for SCN2A. Alex is now the CEO of RogCon, which has a research program (RC-222) developing an antisense oligonucleotide (ASO) treatment for gain-of-function epilepsies.
Hosted by Kris Pierce and David Cunnington, parents of Will, who has SCN2A.
Leave a review and subscribe via Apple Podcasts.
You can also find SCN2A Insights on Spotify, and Google Podcasts or in your podcast app
Links:
- RogCon
- Antisense oligonucleotide therapy for SCN2A gain-of-function epilepsies – poster presented at AES 2018
See omnystudio.com/listener for privacy information.
28 episodes
Share
